AOP-Wiki

API

All KERs

Showing 2276 to 2300 of 2767 KERs

ID	Upstream Event	Downstream Event	Creation Date	Last Updated	AOPs

759	188: Neuroinflammation	385: Synaptogenesis, Decreased	Nov 29, 2016	Dec 3, 2016	None
906	188: Neuroinflammation	890: Degeneration of dopaminergic neurons of the nigrostriatal pathway	Nov 29, 2016	Aug 25, 2017	2 AOPs 3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits 471: Various neuronal effects induced by elavl3, sox10, and mbp
1687	188: Neuroinflammation	55: Cell injury/death	Nov 9, 2017	Nov 7, 2019	2 AOPs 17: Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory 490: Co-activation of IP3R and RyR leads to socio-economic burden through reduced IQ and non-cholinergic mechanisms
2288	188: Neuroinflammation	1841: Encephalitis	Feb 23, 2021	Feb 23, 2021	1 AOP 374: Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis
2500	188: Neuroinflammation	386: Neuronal network function, Decreased	Oct 26, 2021	Oct 26, 2021	1 AOP 429: A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants
2717	188: Neuroinflammation	1825: Increase, Cell death	Jul 25, 2022	Jul 25, 2022	None
210	191: Neuronal dysfunction	188: Neuroinflammation	Nov 29, 2016	Nov 29, 2016	None
2941	191: Neuronal dysfunction	2150: Neurological disorder	Jun 15, 2023	Jun 15, 2023	2 AOPs 498: Increased LCN2/iron complex leading to neurological disorders 471: Various neuronal effects induced by elavl3, sox10, and mbp
3257	2243: NTE, inhibited	2244: LPS, increased	Sep 6, 2024	Sep 26, 2024	2 AOPs 535: Inhibition of neuropathy target esterase leading to delayed neuropathy via lysolecithin cell membrane integration 536: Inhibition of neuropathy target esterase leading to delayed neuropathy via increased inflammation
2457	1915: Neutrophil activation, Increased	1857: Platelet-neutrophil interactions, Increased	Aug 4, 2021	Aug 4, 2021	1 AOP 412: Endothelial cell dysfunction leading to thromboinflammation
1556	1417: NFE2/Nrf2 repression	1419: Reduced, FXR activity	Jun 2, 2017	Jun 2, 2017	1 AOP 232: NFE2/Nrf2 repression to steatosis
2979	1417: NFE2/Nrf2 repression	1969: Increase, Oxidative Stress	Aug 19, 2023	Aug 19, 2023	2 AOPs 507: Nrf2 inhibition leading to vascular disrupting effects via inflammation pathway 509: Nrf2 inhibition leading to vascular disrupting effects through activating apoptosis signal pathway and mitochondrial dysfunction
2984	1417: NFE2/Nrf2 repression	2162: Activation, HIF1α	Aug 20, 2023	Aug 20, 2023	1 AOP 508: Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway
3035	1417: NFE2/Nrf2 repression	2009: Activation, inflammation pathway	Aug 28, 2023	Aug 28, 2023	1 AOP 507: Nrf2 inhibition leading to vascular disrupting effects via inflammation pathway
2414	1895: inflammasome activity, increased	1868: Hyperinflammation	Jun 25, 2021	Jun 25, 2021	1 AOP 406: SARS-CoV-2 infection leading to hyperinflammation
2667	2007: Non-coding RNA expression，alteration	2009: Activation, inflammation pathway	Jun 17, 2022	Jun 17, 2022	1 AOP 452: Adverse outcome pathway of PM-induced respiratory toxicity
2668	2007: Non-coding RNA expression，alteration	1392: Oxidative Stress	Jun 17, 2022	Jun 17, 2022	1 AOP 452: Adverse outcome pathway of PM-induced respiratory toxicity
2670	2007: Non-coding RNA expression，alteration	2012: Fibroblast proliferation and differentiation	Jun 17, 2022	Jun 17, 2022	1 AOP 452: Adverse outcome pathway of PM-induced respiratory toxicity
2671	2007: Non-coding RNA expression，alteration	1262: Apoptosis	Jun 17, 2022	Jun 17, 2022	1 AOP 452: Adverse outcome pathway of PM-induced respiratory toxicity
2672	2007: Non-coding RNA expression，alteration	1945: Dysfunctional autophagy	Jun 17, 2022	Jun 17, 2022	1 AOP 452: Adverse outcome pathway of PM-induced respiratory toxicity
3203	2007: Non-coding RNA expression，alteration	1457: EMT	May 1, 2024	May 1, 2024	1 AOP 452: Adverse outcome pathway of PM-induced respiratory toxicity
1287	1235: Non-neuronal production of IL-8/CXCL1, Epithelial irritation	1218: Opening of calcium channel, Calcium influx	Nov 29, 2016	Dec 3, 2016	None
1277	1224: Non-neuronal production of TNF, Epithelial irritation	1225: Leukocyte infiltration	Nov 29, 2016	Dec 3, 2016	None
1288	1224: Non-neuronal production of TNF, Epithelial irritation	1218: Opening of calcium channel, Calcium influx	Nov 29, 2016	Dec 3, 2016	None
884	862: Not Increased, Circulating Ketone Bodies	863: Increased, Catabolism of Muscle Protein	Nov 29, 2016	Jun 11, 2018	1 AOP 6: Antagonist binding to PPARα leading to body-weight loss

Key Event Relationships (KERs)

All KERs